Showing results (251-260 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|August 14, 2015
Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinomaMengzhou Guo, Yiyi Yu, Yan Wang, et al.
Medical Oncology (Northwood, London, England)|August 15, 2015
Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in control of cervical squamous cell carcinoma than that of cervical adenocarcinomaYanli Xiong, Jia Liu, Shu Chen, et al.
Medical Oncology (Northwood, London, England)|August 24, 2015
Screening of multi-targeted natural compounds for receptor tyrosine kinases inhibitors and biological evaluation on cancer cell lines, in silico and in vitroPushpendra Singh, Felix Bast
Medical Oncology (Northwood, London, England)|June 10, 2016
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patientsPierfrancesco Franco, Francesca Arcadipane, Riccardo Ragona, et al.
Medical Oncology (Northwood, London, England)|June 10, 2016
Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivoMeng Gao, Yanyan Ma, Robert C Bast, et al.
Medical Oncology (Northwood, London, England)|May 5, 2019
Correction to: Expression of Concern: Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancerZhifeng Lin, Liwen Xiong, Qiang Lin
Medical Oncology (Northwood, London, England)|May 20, 2019
Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomographyChiaki Inagaki, Tatsunori Shimoi, Hitomi Sumiyoshi Okuma, et al.
Medical Oncology (Northwood, London, England)|August 4, 2018
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitorsGrzegorz Helbig
Medical Oncology (Northwood, London, England)|May 16, 2019
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancerHisashi Tanaka, Kageaki Taima, Masamichi Itoga, et al.
Medical Oncology (Northwood, London, England)|June 9, 2018
MGMT promoter methylation is not correlated with integrin expression in malignant gliomas: clarifying recent clinical trial resultsOliver Schnell, Valerie Albrecht, David Pfirrmann, et al.
Pageof 570